Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of high and low-dose simvastatin on vascular oxidative stress and neurological outcomes in ischemic stroke patients has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Thammasat University | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED